DUBLIN, Jan. 27, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic ...
September 22, 2023 – Largo, Florida, VistaPharm LLC is voluntarily recalling one (1) lot of Sucralfate Oral Suspension, 1g/10mL, to the consumer level, due to Bacillus cereus contamination in the ...
Credit: FDA. The affected product was found to be contaminated with Bacillus cereus. VistaPharm is recalling 1 lot of Sucralfate Oral Suspension 1g/10mL due to microbial contamination. The product is ...
Endo's Par unit is introducing an authorized generic of Allergan's Carafate (sucralfate) oral suspension 1gm/10 mL. "Par is proud to partner with Allergan to bring the authorized generic of Carafate ...
BRIDGEWATER, NJ.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has received final U.S. Food and Drug Administration approval on its Abbreviated New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback